US 7018627B1
· Gray et al.
· 2006
[cited by applicant]
US 8563476B2
· Lillard, Jr.
· 2013
[cited by examiner]
US 20060057112A1
· Gray et al.
· 2006
[cited by applicant]
WO WO9640923A1
· 1996
[cited by applicant]
WO WO200078334A1
· 2000
[cited by applicant]
WO WO2009143843A1
· 2009
[cited by applicant]
WO WO2011139738A1
· 2011
[cited by applicant]
WO WO2013056716A1
· 2013
[cited by applicant]
WO WO2014028644A1
· 2014
[cited by applicant]
WO WO2014037811A2
· 2014
[cited by applicant]
WO WO2014170389A1
· 2014
[cited by applicant]
Harrington et al., Int'l. J. Psychiatry in Medicine, vol. 40(2) 163-181, 2010.
[cited by examiner]
Cleeland, Seminars in Radiation Oncology, vol. 10, No. 3 Jul. 2000: pp. 175-190.
[cited by examiner]
American Cancer Society, https://www.cancer.org/cancer/diagnosis-staging/signs-and-symptoms-of-cancer.html, 4 pages, accessed Sep. 5, 2024.
[cited by examiner]
Andersen MH et al., “Phosphorylated Peptides can be Transported by TAP Molecules, Presented by Class I MHC Molecules, and Recognized by Phosphopeptide-Specific CTL,” J Immunol, 163: 3812-3818, 1999.
[cited by applicant]
Greenspan et al., “Defining epitopes: It's not as easy as it seems,” Nature Biotechnology, 1999, 7: 936-937.
[cited by applicant]
Guo et al., “Macrophage-Derived Chemokine Gene Transfer Results in Tumor Regression in Murine Lung Carcinoma Model through Efficient Induction of Antitumor Immunity,” Gene Therapy, vol. 9, No. 12, 2002, 793-803.
[cited by applicant]
Kovjazin et al., “The use of signal peptide domains as vaccine candidates,” Human Vaccines & Immunotherapeutics, Sep. 2014, 10:9, 2733-2740.
[cited by applicant]
Qin et al., “CCL22 Recruits CD4-positive CD25-positive Regulatory T Cells into Malignant Pleural Effusion,” Clin Cancer Res. 15(7), 2231-2237, 2009.
[cited by applicant]
Sabado et al., “Dendritic cell-based immunotherapy,” Cell Research (2017) 27:74-95.
[cited by applicant]
Calis, Jorg J. A. et al., “Properties of MHC Class I Presented Peptides That Enhance Immunogenicity”, PLOS Computational Biology 9(10):e1003266, 1-13 (2013).
[cited by applicant]
Chang M S. et al., “Molecular cloning and functional characterization of a novel CC chemokine, stimulated T cell chemotactic protein (STCP-1) that specifically acts on activated T lymphocytes”, Journal of Biological Che…
[cited by applicant]
Comber, J. D. and Philip, R., “MHC class I antigen presentation and implications for developing a new generation of therapeutic vaccines,” Ther Adv Vaccines, 2(3):77-89 (2014).
[cited by applicant]
Purcell, Anthony W. et al., “More Than One Reason to Rethink the Use of Peptides in Vaccine Design”, Nature Reviews | Drug Discovery 6(5):404-414 (2007).
[cited by applicant]